A novel combination therapy offers better outcomes for patients with KRAS G12C metastatic colorectal cancer that have stopped ...

The truth behind the rise in colon cancer and the signs to look for - If trends continue, colorectal cancer could become the leading cause of cancer-related death among young adults ...

Researchers at , Sweden, have discovered a previously unknown type of connective tissue cells that surround cancer cells in pancreatic tumors.

Researchers found that the toxin’s negative effects begin in childhood. In other news, contrary to what has been said, the food industry says no agreement is in place with the HHS to remove artificial ...

A novel approach to tumor-infiltrating lymphocyte therapy yielded higher response rates among patients with metastatic ...

The FDA has approved Cabometyx for some patients 12 years old and older with previously treated neuroendocrine tumors.

Based on the phase 3 CABINET trial, the FDA approved Cabometyx for some patients with previously treated neuroendocrine ...

Jennifer Chan, MD, MPH, discussed outcomes of treating neuroendocrine tumors (NETs) with cabozantinib depending on whether they were pancreatic NETs or extrapancreatic NETs.

Discussion: This study provides a comprehensive overview of research trends and highlights emerging directions, aiming to advance scientific and clinical applications of gut microbiota in ...

King Charles III spent a short period of time in hospital on Thursday after experiencing temporary side effects during cancer treatment, Buckingham Palace said. The King returned to Clarence House ...